3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Thyroid Nodule
4
Prostatic Neoplasms
4
Thyroid Cancer, Papillary
3
Uterine Cervical Neoplasms
2
Papillomavirus Infections
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Thyroid Neoplasms
1
Recurrence
1
Prostatic Hyperplasia
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
HIV Infections
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Depression
1
Carcinoma, Hepatocellular
1
Anxiety Disorders
1
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Urination
1
Transurethral Resection of Prostate
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Finasteride
1
Dutasteride
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Prostatic Hyperplasia
×
Transurethral Resection of Prostate
×
Clear all
NCT06116851
2023-11-03
PROMIC
Turku University Hospital
Recruiting
300 enrolled